Catalyst Wire Dossier Catalyst Wire Dossier

Sitravatinib

sitravatinib · Mirati Therapeutics
Drug timelines are a Plus or Pro feature.

24 regulatory and trial events tracked for Sitravatinib, covering 2021-05-19 to 2026-08-04. Get the full timeline:

Most recent: Clinical Trial Results: Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical Benefit From Parent Study [Phase 2, Phase 3]

See pricing